Service Search Product Search Gene Search
HOME

SERVICES

• Protein Biotinylation Service • Custom Lysate Preparation Service • Immunogenicity Test Service > Anti-Drug Antibody (ADA) Evaluation Service > Neutralizing Antibody (NAb) Test Service • Anti-Drug Antibody (ADA) Evaluation Service • Neutralizing Antibody (NAb) Test Service • Thanksgiving Day Sale • Enzyme Target & Activator & Inhibitor Screening Service • GPCR Screening Service • Ion Channel Screening Service • Bio-layer Interferometry (BLI) Service • Electrophoretic Mobility Shift Assay (EMSA) Service • Transcription Factor Analysis > Electrophoretic Mobility Shift Assay (EMSA) Service > Chromatin Immunoprecipitation (ChIP) Assay Service > DNase I Footprinting Assay Service • Transporter Screening Service • Chromatin Immunoprecipitation (ChIP) Assay Service • Enzyme Activity Assay Service • DNase I Footprinting Assay Service • Co-Immunoprecipitation (Co-IP) • Surface plasmon resonance (SPR) Service • Pull Down Assay • Protein Mutant Library Construction • C1 Expression System • Protein Conjugation Service on Beads • Bacteria Expression • Yeast Expression • Mammalian Cell Expression • Insect Cell Expression • Animal-free Expression • Cell-free protein expression • Large-scale Protein Production • PEGylation Products and Services > Custom PEGylation Services > PEGylation Products • Basic Protein Characterization • Protein Labeling • Stable Cell Line Construction for Protein Expression • Protein Mutagenesis • Protein Interaction Analysis Services > Bio-layer Interferometry (BLI) Service > Co-Immunoprecipitation (Co-IP) > Surface plasmon resonance (SPR) Service > Pull Down Assay > Yeast Two-Hybrid Screening > Membrane-based Yeast Two-Hybrid Screening > CLIP-Seq Service > Protein Binding Site Mapping • Yeast Two-Hybrid Screening • Membrane-based Yeast Two-Hybrid Screening • Recombinant Protein or Antibody Production • Protein Expression Systems > Nicotiana tabacum Expression System > Bacterial Expression Systems(E. coli / Bacillus) > Yeast Expression Systems(P pastoris / S cerevisiae) > Baculovirus-insect Cell Expression Systems > Mammalian Expression Systems(CHO / 293) • PEGylation Services • Stable Cell Line Construction for Protein Expression • Process Development • cGMP Manufacturing • QC and QA • Bacterial Manufacturing • CLIP-Seq Service • Protein Binding Site Mapping • Quantum Dot Labeling • Protein Expression > Custom Lysate Preparation Service > C1 Expression System > Protein Co-expression Service in E. coli System > Protein Co-expression Service in Mammalian Cells > Trimeric Protein Production Service • Protein Co-expression Service in E. coli System • Protein Co-expression Service in Mammalian Cells • NovEgg Expression System • ADME/Tox Prediction • Pharmacophore Modeling • Screening and Profiling Services > Enzyme Target & Activator & Inhibitor Screening Service > GPCR Screening Service > Ion Channel Screening Service > Transporter Screening Service • Trimeric Protein Production Service • Incorporation of Bioorthogonal Handles > Incorporation of Unnatural Amino Acids > Incorporation of Unnatural Sugars > Direct Chemical Modification • Incorporation of Unnatural Amino Acids • Incorporation of Unnatural Sugars • Protein/peptide Crosslinking > Enzymatic Crosslinking Services > Photocrosslinking Services > Chemical Crosslinking Services • Enzymatic Crosslinking Services • Photocrosslinking Services • Chemical Crosslinking Services • Direct Chemical Modification • Protein-fluorophore Bioconjugation • Custom PEGylation Services • PEGylation Products • Target Protein Degradation - Proteolysis Targeting Chimera (PROTAC) Nicotiana tabacum Expression System

CONTACT US

Tel: 1-631-448-8149
Fax: 1-631-938-8127

Target Protein Degradation - Proteolysis Targeting Chimera (PROTAC)

In mammalian cells, protein degradation is mainly carried out by the ubiquitin-proteasome system to dispose of damaged or redundant proteins. Ubiquitin can be attached to the substrate protein through a series of enzymatic reactions leading to the covalent bonding between the C-terminal glycine of ubiquitin and the lysine residue of the substrate. Ubiquitin-tagged proteins are eventually recognized and destructed by proteasome. In spite of the high complexity of ubiquitin system, it is not surprising that some components or processes in this system could provide promising therapeutic intervention for a variety of diseases, including cancer and neurodegenerative diseases. One good example is the E3 ligases, which regulate the attachment of ubiquitin tags to substrate proteins for subsequent degradation.

Illustration of the PROTAC strategy
Illustration of the PROTAC strategy

Recently, Arvinas has developed a chemical strategy called Proteolysis Targeting Chimera (PROTAC) for E3 ligase-based degradation of target proteins.1 In principle, this method can be used to selectively degrade any protein of interest by bringing the target protein into proximity of the E3 ligase for proteasome-mediated proteolysis. Pioneered by Arvinas, PROTAC is becoming an promising strategy to target the so called “undruggable” proteins such as estrogen-related receptor alpha, cellular retinoic acid binding proteins, and BRD4.2 The key step of PROTAC is the construction a heterobifunctional small molecule that has two warheads – one binds to the target protein, and the other recruits the E3 ligase. 

Target Protein Degradation - Proteolysis Targeting Chimera (PROTAC)

Profacgen, a leading biotech CRO, has been extensively working on bioconjugation services and assay development for more than a decade. Inspired by the discovery of PROTAC, we now offer small molecule-based conjugation services to help our customers develop a new class of therapeutic agents targeting cancers and other difficult-to-treat diseases. This degradation-oriented method is generally more advantageous than traditional enzyme inhibitory strategy in that PROTAC can:

  • Remove target proteins rather than blocking them;
  • Avoid using high dosage to achieve sufficient inhibition;
  • Reduce toxicity;
  • Degrade “uninhibitable” proteins.

Our services consist of different modules that cover every aspect of PROTAC development, from ligand identification to biological evaluation. Customers are encouraged to choose individual modules that best fit their needs. To achieve the best efficacy, we do recommend our one-stop service package that delivers unrivaled value and will take care of your research project from scratch to full development.  

Target Protein Degradation - Proteolysis Targeting Chimera (PROTAC)
Ligand identification
Affinity assays to confirm binding potency,
Structural modification, molecular docking.

 

Target Protein Degradation - Proteolysis Targeting Chimera (PROTAC)
Chemical conjugation
Modification of ligands, linker development,
conjugation chemistry, full characterization.
Target Protein Degradation - Proteolysis Targeting Chimera (PROTAC)
Biological evaluation
Enzyme inhibition, protein degradation, in vitro
ADME, in vivo tests on animal models.

For more information regarding Profacgen’s PROTAC service, please contact us or call 1-631-448-8149. Our customer service representatives are available 24 hours a day, Monday through Friday, to assist you.

References:
1. Lai, A. C.; et al. Modular PROTAC Design for the Degradation of Oncogenic BCR‐ABL. Angew. Chem. Int. Ed. 2016, 55: 807-810. 
2. Winter, G. E.; et al. Phthalimide conjugation as a strategy for in vivo target protein degradation. Science 2015, 348 (6241), 1376-1381.

CONTACT US
Email: info@profacgen.com
Tel: 1-631-448-8149
Fax: 1-631-938-8127
Address: 45-1 Ramsey Road, Shirley, NY 11967, USA